

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ribosomal small subunit assembly (GO:0000028) | 5.43275132 |
| 2 | glucocorticoid biosynthetic process (GO:0006704) | 4.94749495 |
| 3 | protein complex biogenesis (GO:0070271) | 4.52769065 |
| 4 | proteasome assembly (GO:0043248) | 4.51354228 |
| 5 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 4.47976935 |
| 6 | signal peptide processing (GO:0006465) | 4.45565221 |
| 7 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 4.28286768 |
| 8 | NADH dehydrogenase complex assembly (GO:0010257) | 4.28286768 |
| 9 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 4.28286768 |
| 10 | mitochondrial respiratory chain complex assembly (GO:0033108) | 4.14498869 |
| 11 | purine nucleotide salvage (GO:0032261) | 4.08015110 |
| 12 | respiratory chain complex IV assembly (GO:0008535) | 4.07036102 |
| 13 | cytidine deamination (GO:0009972) | 4.03489857 |
| 14 | cytidine metabolic process (GO:0046087) | 4.03489857 |
| 15 | cytidine catabolic process (GO:0006216) | 4.03489857 |
| 16 | cytochrome complex assembly (GO:0017004) | 3.95890782 |
| 17 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.93246986 |
| 18 | branched-chain amino acid catabolic process (GO:0009083) | 3.88802139 |
| 19 | oxidative phosphorylation (GO:0006119) | 3.87209646 |
| 20 | chaperone-mediated protein transport (GO:0072321) | 3.82277606 |
| 21 | DNA deamination (GO:0045006) | 3.79680824 |
| 22 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.78694961 |
| 23 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.77474154 |
| 24 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.71382171 |
| 25 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.66909098 |
| 26 | xenobiotic catabolic process (GO:0042178) | 3.66344258 |
| 27 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.63519076 |
| 28 | GDP-mannose metabolic process (GO:0019673) | 3.60047131 |
| 29 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.59050696 |
| 30 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.59050696 |
| 31 | cullin deneddylation (GO:0010388) | 3.58127139 |
| 32 | protein deneddylation (GO:0000338) | 3.56782636 |
| 33 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.54748383 |
| 34 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.54748383 |
| 35 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.54748383 |
| 36 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.54138074 |
| 37 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.52241927 |
| 38 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.45559439 |
| 39 | negative regulation of ligase activity (GO:0051352) | 3.45559439 |
| 40 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.45228257 |
| 41 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.41057529 |
| 42 | amino acid salvage (GO:0043102) | 3.39783414 |
| 43 | L-methionine salvage (GO:0071267) | 3.39783414 |
| 44 | L-methionine biosynthetic process (GO:0071265) | 3.39783414 |
| 45 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.39292685 |
| 46 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.39292685 |
| 47 | telomere maintenance via recombination (GO:0000722) | 3.38119934 |
| 48 | regulation of mitochondrial translation (GO:0070129) | 3.35958519 |
| 49 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.33251204 |
| 50 | aerobic respiration (GO:0009060) | 3.30589716 |
| 51 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.29787880 |
| 52 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.29105135 |
| 53 | regulation of metalloenzyme activity (GO:0048552) | 3.28759862 |
| 54 | glucocorticoid metabolic process (GO:0008211) | 3.28188990 |
| 55 | valine metabolic process (GO:0006573) | 3.28120662 |
| 56 | neutrophil activation involved in immune response (GO:0002283) | 3.26526592 |
| 57 | branched-chain amino acid metabolic process (GO:0009081) | 3.26139223 |
| 58 | ATP synthesis coupled proton transport (GO:0015986) | 3.25335247 |
| 59 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.25335247 |
| 60 | DNA strand elongation (GO:0022616) | 3.21375232 |
| 61 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 3.18604266 |
| 62 | C21-steroid hormone biosynthetic process (GO:0006700) | 3.16644413 |
| 63 | metallo-sulfur cluster assembly (GO:0031163) | 3.12176349 |
| 64 | iron-sulfur cluster assembly (GO:0016226) | 3.12176349 |
| 65 | peroxisome fission (GO:0016559) | 3.11241465 |
| 66 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.10628289 |
| 67 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 3.09639065 |
| 68 | lactate metabolic process (GO:0006089) | 3.06331144 |
| 69 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 3.02215430 |
| 70 | purine nucleobase biosynthetic process (GO:0009113) | 3.02181594 |
| 71 | purine-containing compound salvage (GO:0043101) | 2.99826059 |
| 72 | nucleobase biosynthetic process (GO:0046112) | 2.99824922 |
| 73 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.96882339 |
| 74 | cotranslational protein targeting to membrane (GO:0006613) | 2.96615298 |
| 75 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.95747790 |
| 76 | androgen biosynthetic process (GO:0006702) | 2.93626154 |
| 77 | oxaloacetate metabolic process (GO:0006107) | 2.92338137 |
| 78 | ubiquinone biosynthetic process (GO:0006744) | 2.90374470 |
| 79 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.89012645 |
| 80 | 7-methylguanosine mRNA capping (GO:0006370) | 2.88661951 |
| 81 | protein targeting to ER (GO:0045047) | 2.87712810 |
| 82 | positive regulation of ligase activity (GO:0051351) | 2.87079332 |
| 83 | protein localization to endoplasmic reticulum (GO:0070972) | 2.86879287 |
| 84 | mitotic recombination (GO:0006312) | 2.86662037 |
| 85 | protein targeting to mitochondrion (GO:0006626) | 2.84907254 |
| 86 | respiratory electron transport chain (GO:0022904) | 2.84882703 |
| 87 | COPI coating of Golgi vesicle (GO:0048205) | 2.83205442 |
| 88 | Golgi transport vesicle coating (GO:0048200) | 2.83205442 |
| 89 | formation of translation preinitiation complex (GO:0001731) | 2.82837798 |
| 90 | termination of RNA polymerase III transcription (GO:0006386) | 2.82611900 |
| 91 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.82611900 |
| 92 | pentose metabolic process (GO:0019321) | 2.82450423 |
| 93 | NADH metabolic process (GO:0006734) | 2.81727279 |
| 94 | transcription-coupled nucleotide-excision repair (GO:0006283) | 2.81384166 |
| 95 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.80583672 |
| 96 | RNA capping (GO:0036260) | 2.80346008 |
| 97 | 7-methylguanosine RNA capping (GO:0009452) | 2.80346008 |
| 98 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.80190419 |
| 99 | electron transport chain (GO:0022900) | 2.79602867 |
| 100 | mannosylation (GO:0097502) | 2.78957975 |
| 101 | pseudouridine synthesis (GO:0001522) | 2.77869767 |
| 102 | progesterone metabolic process (GO:0042448) | 2.75227413 |
| 103 | positive regulation of defense response to virus by host (GO:0002230) | 2.74792948 |
| 104 | adenosine metabolic process (GO:0046085) | 2.74728353 |
| 105 | response to interferon-beta (GO:0035456) | 2.74319843 |
| 106 | platelet dense granule organization (GO:0060155) | 2.73542348 |
| 107 | galactose metabolic process (GO:0006012) | 2.73214282 |
| 108 | cellular response to antibiotic (GO:0071236) | 2.71441021 |
| 109 | viral protein processing (GO:0019082) | 2.70724764 |
| 110 | positive regulation of cell cycle arrest (GO:0071158) | 2.70715199 |
| 111 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.70542309 |
| 112 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.70190695 |
| 113 | telomere maintenance via telomere lengthening (GO:0010833) | 2.69193110 |
| 114 | sequestering of actin monomers (GO:0042989) | 2.69033557 |
| 115 | protein neddylation (GO:0045116) | 2.68609613 |
| 116 | translation (GO:0006412) | 2.68577092 |
| 117 | viral mRNA export from host cell nucleus (GO:0046784) | 2.67837339 |
| 118 | establishment of protein localization to mitochondrion (GO:0072655) | 2.65812723 |
| 119 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.65702696 |
| 120 | ketone biosynthetic process (GO:0042181) | 2.65435971 |
| 121 | de novo protein folding (GO:0006458) | 2.65421636 |
| 122 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.65271259 |
| 123 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.65271259 |
| 124 | de novo posttranslational protein folding (GO:0051084) | 2.64878512 |
| 125 | regulation of cellular amine metabolic process (GO:0033238) | 2.64301894 |
| 126 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.63215549 |
| 127 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.63215549 |
| 128 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.62600215 |
| 129 | methionine biosynthetic process (GO:0009086) | 2.60946448 |
| 130 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.60274228 |
| 131 | peptidyl-histidine modification (GO:0018202) | 2.59518297 |
| 132 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.57042659 |
| 133 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.57042659 |
| 134 | C21-steroid hormone metabolic process (GO:0008207) | 2.54935440 |
| 135 | negative regulation of neurological system process (GO:0031645) | 2.54852700 |
| 136 | nucleotide salvage (GO:0043173) | 2.54681861 |
| 137 | regulation of chronic inflammatory response (GO:0002676) | 2.52224091 |
| 138 | cellular response to zinc ion (GO:0071294) | 2.48440204 |
| 139 | regulation of regulatory T cell differentiation (GO:0045589) | 2.47525638 |
| 140 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.46951450 |
| 141 | L-phenylalanine catabolic process (GO:0006559) | 2.46951450 |
| 142 | pyrimidine nucleoside catabolic process (GO:0046135) | 2.46663445 |
| 143 | positive regulation of amino acid transport (GO:0051957) | 2.45933204 |
| 144 | purine deoxyribonucleoside triphosphate metabolic process (GO:0009215) | 2.43984754 |
| 145 | neutrophil activation (GO:0042119) | 2.43254600 |
| 146 | glucosamine-containing compound catabolic process (GO:1901072) | 2.42316700 |
| 147 | cellular response to interferon-beta (GO:0035458) | 2.42263646 |
| 148 | regulation of transmission of nerve impulse (GO:0051969) | 2.39482118 |
| 149 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.37909268 |
| 150 | positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:00357 | 2.37478560 |
| 151 | immunoglobulin mediated immune response (GO:0016064) | 2.37470062 |
| 152 | autophagic vacuole fusion (GO:0000046) | 2.36870267 |
| 153 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.36448506 |
| 154 | L-phenylalanine metabolic process (GO:0006558) | 2.36448506 |
| 155 | negative regulation of thymocyte apoptotic process (GO:0070244) | 2.35768394 |
| 156 | response to methylmercury (GO:0051597) | 2.33312419 |
| 157 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 2.33243063 |
| 158 | granulocyte activation (GO:0036230) | 2.32160272 |
| 159 | ubiquinone metabolic process (GO:0006743) | 2.32159201 |
| 160 | negative regulation of lipid storage (GO:0010888) | 2.31949135 |
| 161 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.29451361 |
| 162 | short-chain fatty acid metabolic process (GO:0046459) | 2.27434958 |
| 163 | B cell mediated immunity (GO:0019724) | 2.26192973 |
| 164 | leukocyte degranulation (GO:0043299) | 2.26129761 |
| 165 | deoxyribonucleotide catabolic process (GO:0009264) | 2.24378040 |
| 166 | positive regulation of hormone biosynthetic process (GO:0046886) | 2.22897766 |
| 167 | quinone biosynthetic process (GO:1901663) | 2.20657773 |
| 168 | deoxyribose phosphate catabolic process (GO:0046386) | 2.20538047 |
| 169 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.17363103 |
| 170 | benzene-containing compound metabolic process (GO:0042537) | 2.15163187 |
| 171 | AMP metabolic process (GO:0046033) | 2.14741302 |
| 172 | GMP metabolic process (GO:0046037) | 2.12857144 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.08073838 |
| 2 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.93393099 |
| 3 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.88509894 |
| 4 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.74624448 |
| 5 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.73181686 |
| 6 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.63456731 |
| 7 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.60208881 |
| 8 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.29751666 |
| 9 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 3.15960057 |
| 10 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 3.13090450 |
| 11 | * MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.99836685 |
| 12 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.95707579 |
| 13 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.93936427 |
| 14 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.85107273 |
| 15 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.77043119 |
| 16 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.69363900 |
| 17 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.67184059 |
| 18 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.64152023 |
| 19 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.63165537 |
| 20 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.60664427 |
| 21 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.53552137 |
| 22 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.53130092 |
| 23 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.48124405 |
| 24 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 2.42219013 |
| 25 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.35103060 |
| 26 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.25080051 |
| 27 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 2.22520356 |
| 28 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.22327110 |
| 29 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.19922675 |
| 30 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.16450673 |
| 31 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.15435014 |
| 32 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.14529585 |
| 33 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.10226586 |
| 34 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.06978606 |
| 35 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.03739223 |
| 36 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.02528828 |
| 37 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 2.02314175 |
| 38 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.98982776 |
| 39 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.98235466 |
| 40 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.97583493 |
| 41 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.96726774 |
| 42 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.94475499 |
| 43 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.92039194 |
| 44 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.91217119 |
| 45 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.89617099 |
| 46 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.81320917 |
| 47 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.80791287 |
| 48 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.71271211 |
| 49 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.70145306 |
| 50 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.68358116 |
| 51 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.60832942 |
| 52 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.60530894 |
| 53 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.58760682 |
| 54 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.58372058 |
| 55 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.56919242 |
| 56 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.56321564 |
| 57 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.54871257 |
| 58 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.53068692 |
| 59 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.51755381 |
| 60 | * ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.48432586 |
| 61 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.47815627 |
| 62 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.47379999 |
| 63 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.47284385 |
| 64 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.45341146 |
| 65 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.44570351 |
| 66 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.40249997 |
| 67 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.38632307 |
| 68 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.38542512 |
| 69 | GATA3_26560356_Chip-Seq_TH2_Human | 1.38278649 |
| 70 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.35776101 |
| 71 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.35362919 |
| 72 | MYB_26560356_Chip-Seq_TH2_Human | 1.34758513 |
| 73 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.33506006 |
| 74 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.32906164 |
| 75 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.31894772 |
| 76 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.31871706 |
| 77 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.31486212 |
| 78 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.30511717 |
| 79 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27628127 |
| 80 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.25912314 |
| 81 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.25829196 |
| 82 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.25248937 |
| 83 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.25087599 |
| 84 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.24941367 |
| 85 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.23615473 |
| 86 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.23347728 |
| 87 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.22100602 |
| 88 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.19351611 |
| 89 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.18825299 |
| 90 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.17561188 |
| 91 | * PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.13119095 |
| 92 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.12646653 |
| 93 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.11906551 |
| 94 | VDR_22108803_ChIP-Seq_LS180_Human | 1.10696699 |
| 95 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.08671551 |
| 96 | * SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.07935443 |
| 97 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.07892849 |
| 98 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.06626199 |
| 99 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.06526142 |
| 100 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.06332689 |
| 101 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.05267597 |
| 102 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.04745224 |
| 103 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.03691229 |
| 104 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.02977773 |
| 105 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.02067887 |
| 106 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.00843402 |
| 107 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.00397320 |
| 108 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.99949781 |
| 109 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.99619273 |
| 110 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.99073068 |
| 111 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.98629492 |
| 112 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.98049283 |
| 113 | * SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.98015279 |
| 114 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.98009637 |
| 115 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.97782383 |
| 116 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.97655197 |
| 117 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.96675765 |
| 118 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.96490945 |
| 119 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.96207465 |
| 120 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.96051274 |
| 121 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.94602145 |
| 122 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.94195154 |
| 123 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.92917473 |
| 124 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.92558109 |
| 125 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.92558109 |
| 126 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.91718645 |
| 127 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.90956206 |
| 128 | SPI1_23127762_ChIP-Seq_K562_Human | 0.90402087 |
| 129 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.89994963 |
| 130 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.89834319 |
| 131 | * AR_20517297_ChIP-Seq_VCAP_Human | 0.89613495 |
| 132 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.87804328 |
| 133 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.87464630 |
| 134 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.85356657 |
| 135 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.84606234 |
| 136 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.84409240 |
| 137 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.83896750 |
| 138 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.83612096 |
| 139 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.83078130 |
| 140 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.81794851 |
| 141 | GATA1_22025678_ChIP-Seq_K562_Human | 0.81321829 |
| 142 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.80806527 |
| 143 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.80523013 |
| 144 | * POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.79491582 |
| 145 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.79372394 |
| 146 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.79361875 |
| 147 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.78704210 |
| 148 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.76433697 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003806_abnormal_nucleotide_metabolis | 3.68268167 |
| 2 | MP0003186_abnormal_redox_activity | 3.41824492 |
| 3 | MP0001835_abnormal_antigen_presentation | 2.95626919 |
| 4 | MP0009785_altered_susceptibility_to | 2.69886083 |
| 5 | MP0001986_abnormal_taste_sensitivity | 2.58494341 |
| 6 | MP0002148_abnormal_hypersensitivity_rea | 2.49308781 |
| 7 | MP0002396_abnormal_hematopoietic_system | 2.37203875 |
| 8 | MP0001764_abnormal_homeostasis | 2.19790127 |
| 9 | MP0006036_abnormal_mitochondrial_physio | 2.18621498 |
| 10 | MP0008058_abnormal_DNA_repair | 2.16452296 |
| 11 | MP0001661_extended_life_span | 2.15632755 |
| 12 | MP0009333_abnormal_splenocyte_physiolog | 2.11285342 |
| 13 | MP0001853_heart_inflammation | 2.05449937 |
| 14 | MP0006054_spinal_hemorrhage | 2.01005120 |
| 15 | MP0005671_abnormal_response_to | 2.00248741 |
| 16 | MP0004147_increased_porphyrin_level | 1.97911965 |
| 17 | MP0002837_dystrophic_cardiac_calcinosis | 1.97711568 |
| 18 | MP0003656_abnormal_erythrocyte_physiolo | 1.96693462 |
| 19 | MP0009697_abnormal_copulation | 1.91370337 |
| 20 | MP0008995_early_reproductive_senescence | 1.88272857 |
| 21 | MP0005058_abnormal_lysosome_morphology | 1.87949915 |
| 22 | MP0003693_abnormal_embryo_hatching | 1.87904756 |
| 23 | MP0006082_CNS_inflammation | 1.87583021 |
| 24 | MP0000372_irregular_coat_pigmentation | 1.85546760 |
| 25 | MP0003724_increased_susceptibility_to | 1.84323345 |
| 26 | MP0005025_abnormal_response_to | 1.84237984 |
| 27 | MP0010094_abnormal_chromosome_stability | 1.81894926 |
| 28 | MP0003763_abnormal_thymus_physiology | 1.80750472 |
| 29 | MP0002419_abnormal_innate_immunity | 1.79799672 |
| 30 | MP0005397_hematopoietic_system_phenotyp | 1.78206592 |
| 31 | MP0001545_abnormal_hematopoietic_system | 1.78206592 |
| 32 | MP0003183_abnormal_peptide_metabolism | 1.75647952 |
| 33 | MP0008007_abnormal_cellular_replicative | 1.74244145 |
| 34 | MP0005000_abnormal_immune_tolerance | 1.69280755 |
| 35 | MP0002638_abnormal_pupillary_reflex | 1.67451616 |
| 36 | MP0001529_abnormal_vocalization | 1.67449168 |
| 37 | MP0002420_abnormal_adaptive_immunity | 1.67146775 |
| 38 | MP0001819_abnormal_immune_cell | 1.65708471 |
| 39 | MP0004957_abnormal_blastocyst_morpholog | 1.62423139 |
| 40 | MP0002452_abnormal_antigen_presenting | 1.60677361 |
| 41 | MP0002163_abnormal_gland_morphology | 1.60240238 |
| 42 | MP0008057_abnormal_DNA_replication | 1.59675481 |
| 43 | MP0005646_abnormal_pituitary_gland | 1.58151950 |
| 44 | MP0002723_abnormal_immune_serum | 1.57198986 |
| 45 | MP0000013_abnormal_adipose_tissue | 1.55821495 |
| 46 | MP0001800_abnormal_humoral_immune | 1.52746162 |
| 47 | MP0003436_decreased_susceptibility_to | 1.50628324 |
| 48 | MP0003077_abnormal_cell_cycle | 1.49006920 |
| 49 | MP0005387_immune_system_phenotype | 1.48937218 |
| 50 | MP0001790_abnormal_immune_system | 1.48937218 |
| 51 | MP0000490_abnormal_crypts_of | 1.47454178 |
| 52 | MP0000685_abnormal_immune_system | 1.46573191 |
| 53 | MP0002398_abnormal_bone_marrow | 1.45755565 |
| 54 | MP0009764_decreased_sensitivity_to | 1.45323520 |
| 55 | MP0005075_abnormal_melanosome_morpholog | 1.42182126 |
| 56 | MP0002405_respiratory_system_inflammati | 1.41936495 |
| 57 | MP0002132_abnormal_respiratory_system | 1.41245787 |
| 58 | MP0005332_abnormal_amino_acid | 1.40872059 |
| 59 | MP0000639_abnormal_adrenal_gland | 1.37794411 |
| 60 | MP0003646_muscle_fatigue | 1.37690665 |
| 61 | MP0003300_gastrointestinal_ulcer | 1.37571791 |
| 62 | MP0003011_delayed_dark_adaptation | 1.37168076 |
| 63 | MP0003075_altered_response_to | 1.36177748 |
| 64 | MP0000716_abnormal_immune_system | 1.35951209 |
| 65 | MP0000689_abnormal_spleen_morphology | 1.35715554 |
| 66 | MP0005464_abnormal_platelet_physiology | 1.35016066 |
| 67 | MP0003191_abnormal_cellular_cholesterol | 1.34660976 |
| 68 | MP0005410_abnormal_fertilization | 1.33205691 |
| 69 | MP0006035_abnormal_mitochondrial_morpho | 1.32504075 |
| 70 | MP0002876_abnormal_thyroid_physiology | 1.31102968 |
| 71 | MP0005165_increased_susceptibility_to | 1.30561188 |
| 72 | MP0002429_abnormal_blood_cell | 1.30338494 |
| 73 | MP0004084_abnormal_cardiac_muscle | 1.30075116 |
| 74 | MP0001905_abnormal_dopamine_level | 1.27326911 |
| 75 | MP0002722_abnormal_immune_system | 1.25488091 |
| 76 | MP0000343_altered_response_to | 1.25260785 |
| 77 | MP0005319_abnormal_enzyme/_coenzyme | 1.23791610 |
| 78 | MP0003045_fibrosis | 1.19511262 |
| 79 | MP0008469_abnormal_protein_level | 1.18395039 |
| 80 | MP0003172_abnormal_lysosome_physiology | 1.17669371 |
| 81 | MP0010386_abnormal_urinary_bladder | 1.17358886 |
| 82 | MP0001845_abnormal_inflammatory_respons | 1.16306469 |
| 83 | MP0008875_abnormal_xenobiotic_pharmacok | 1.14753350 |
| 84 | MP0005365_abnormal_bile_salt | 1.14502607 |
| 85 | MP0008260_abnormal_autophagy | 1.14383340 |
| 86 | MP0002166_altered_tumor_susceptibility | 1.12830304 |
| 87 | MP0004036_abnormal_muscle_relaxation | 1.12632568 |
| 88 | MP0000858_altered_metastatic_potential | 1.12632152 |
| 89 | MP0005084_abnormal_gallbladder_morpholo | 1.12065421 |
| 90 | MP0003866_abnormal_defecation | 1.10187035 |
| 91 | MP0001727_abnormal_embryo_implantation | 1.10071748 |
| 92 | MP0009379_abnormal_foot_pigmentation | 1.08041098 |
| 93 | MP0001542_abnormal_bone_strength | 1.07806972 |
| 94 | MP0002736_abnormal_nociception_after | 1.06861414 |
| 95 | MP0002019_abnormal_tumor_incidence | 1.05976578 |
| 96 | MP0005670_abnormal_white_adipose | 1.04944202 |
| 97 | MP0004782_abnormal_surfactant_physiolog | 1.04025798 |
| 98 | MP0010155_abnormal_intestine_physiology | 1.02622476 |
| 99 | MP0000358_abnormal_cell_content/ | 1.02206531 |
| 100 | MP0005330_cardiomyopathy | 1.01214288 |
| 101 | MP0004215_abnormal_myocardial_fiber | 1.01148872 |
| 102 | MP0009763_increased_sensitivity_to | 1.00194179 |
| 103 | MP0008004_abnormal_stomach_pH | 0.98604693 |
| 104 | MP0005636_abnormal_mineral_homeostasis | 0.97061089 |
| 105 | MP0002006_tumorigenesis | 0.97046879 |
| 106 | MP0008775_abnormal_heart_ventricle | 0.96901231 |
| 107 | MP0000749_muscle_degeneration | 0.96384127 |
| 108 | MP0001984_abnormal_olfaction | 0.96029155 |
| 109 | MP0002269_muscular_atrophy | 0.95942484 |
| 110 | MP0003950_abnormal_plasma_membrane | 0.95856357 |
| 111 | MP0003111_abnormal_nucleus_morphology | 0.95852987 |
| 112 | MP0005376_homeostasis/metabolism_phenot | 0.94072472 |
| 113 | MP0002095_abnormal_skin_pigmentation | 0.93184897 |
| 114 | MP0010329_abnormal_lipoprotein_level | 0.92080496 |
| 115 | MP0005266_abnormal_metabolism | 0.90579210 |
| 116 | MP0009840_abnormal_foam_cell | 0.90067093 |
| 117 | MP0005535_abnormal_body_temperature | 0.89800495 |
| 118 | MP0000465_gastrointestinal_hemorrhage | 0.89553248 |
| 119 | MP0005171_absent_coat_pigmentation | 0.88611142 |
| 120 | MP0005174_abnormal_tail_pigmentation | 0.88446290 |
| 121 | MP0002254_reproductive_system_inflammat | 0.88105204 |
| 122 | MP0003195_calcinosis | 0.88062931 |
| 123 | MP0002693_abnormal_pancreas_physiology | 0.87455440 |
| 124 | MP0000681_abnormal_thyroid_gland | 0.87312583 |
| 125 | MP0002138_abnormal_hepatobiliary_system | 0.87203707 |
| 126 | MP0008932_abnormal_embryonic_tissue | 0.85399296 |
| 127 | MP0000569_abnormal_digit_pigmentation | 0.85089184 |
| 128 | MP0005166_decreased_susceptibility_to | 0.84972016 |
| 129 | MP0003786_premature_aging | 0.84960740 |
| 130 | MP0004808_abnormal_hematopoietic_stem | 0.84491765 |
| 131 | MP0001533_abnormal_skeleton_physiology | 0.84156163 |
| 132 | MP0002332_abnormal_exercise_endurance | 0.84038560 |
| 133 | MP0005379_endocrine/exocrine_gland_phen | 0.83809417 |
| 134 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.83183204 |
| 135 | MP0004043_abnormal_pH_regulation | 0.82519338 |
| 136 | MP0009643_abnormal_urine_homeostasis | 0.81344641 |
| 137 | MP0000230_abnormal_systemic_arterial | 0.81262054 |
| 138 | MP0000604_amyloidosis | 0.80435786 |
| 139 | MP0001756_abnormal_urination | 0.79714342 |
| 140 | MP0001765_abnormal_ion_homeostasis | 0.79125212 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hepatocellular necrosis (HP:0001404) | 4.83956609 |
| 2 | Hepatic necrosis (HP:0002605) | 4.63527421 |
| 3 | Mitochondrial inheritance (HP:0001427) | 4.52792431 |
| 4 | Acute necrotizing encephalopathy (HP:0006965) | 4.24430169 |
| 5 | Abnormal mitochondria in muscle tissue (HP:0008316) | 4.15876942 |
| 6 | Increased CSF lactate (HP:0002490) | 4.05801470 |
| 7 | Stomatitis (HP:0010280) | 3.71006932 |
| 8 | Type I transferrin isoform profile (HP:0003642) | 3.70460393 |
| 9 | Acute encephalopathy (HP:0006846) | 3.65721553 |
| 10 | Progressive macrocephaly (HP:0004481) | 3.53726537 |
| 11 | Petechiae (HP:0000967) | 3.43298155 |
| 12 | Renal Fanconi syndrome (HP:0001994) | 3.40056980 |
| 13 | Increased hepatocellular lipid droplets (HP:0006565) | 3.35256321 |
| 14 | Generalized aminoaciduria (HP:0002909) | 3.20637101 |
| 15 | Aplastic anemia (HP:0001915) | 3.18429796 |
| 16 | Lipid accumulation in hepatocytes (HP:0006561) | 3.16917417 |
| 17 | Increased serum lactate (HP:0002151) | 3.16733537 |
| 18 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.09357356 |
| 19 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.09357356 |
| 20 | Increased serum pyruvate (HP:0003542) | 3.08891154 |
| 21 | Abnormality of glycolysis (HP:0004366) | 3.08891154 |
| 22 | 3-Methylglutaconic aciduria (HP:0003535) | 2.99919358 |
| 23 | Abnormality of glycolipid metabolism (HP:0010969) | 2.96924446 |
| 24 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.96924446 |
| 25 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.96924446 |
| 26 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.96166104 |
| 27 | Lactic acidosis (HP:0003128) | 2.89475487 |
| 28 | Increased intramyocellular lipid droplets (HP:0012240) | 2.88244410 |
| 29 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.81546009 |
| 30 | Abnormal protein glycosylation (HP:0012346) | 2.80551555 |
| 31 | Abnormal glycosylation (HP:0012345) | 2.80551555 |
| 32 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.80551555 |
| 33 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.80551555 |
| 34 | Exertional dyspnea (HP:0002875) | 2.79544614 |
| 35 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.70483683 |
| 36 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.70483683 |
| 37 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.70483683 |
| 38 | Respiratory failure (HP:0002878) | 2.70235639 |
| 39 | Acute hepatic failure (HP:0006554) | 2.68880366 |
| 40 | Increased muscle lipid content (HP:0009058) | 2.67153820 |
| 41 | Hypothermia (HP:0002045) | 2.65785372 |
| 42 | IgM deficiency (HP:0002850) | 2.64062009 |
| 43 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.63843372 |
| 44 | Abnormal number of erythroid precursors (HP:0012131) | 2.63308590 |
| 45 | Dysostosis multiplex (HP:0000943) | 2.62312031 |
| 46 | Mucopolysacchariduria (HP:0008155) | 2.61229936 |
| 47 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.61229936 |
| 48 | Exercise intolerance (HP:0003546) | 2.60585299 |
| 49 | Abnormality of renal resorption (HP:0011038) | 2.60196482 |
| 50 | Microvesicular hepatic steatosis (HP:0001414) | 2.57745414 |
| 51 | Hypoglycemic coma (HP:0001325) | 2.54867308 |
| 52 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.50931738 |
| 53 | Reduced antithrombin III activity (HP:0001976) | 2.48175765 |
| 54 | Myositis (HP:0100614) | 2.47544822 |
| 55 | Prolonged neonatal jaundice (HP:0006579) | 2.46271692 |
| 56 | Thrombocytosis (HP:0001894) | 2.44265819 |
| 57 | Cerebral edema (HP:0002181) | 2.38900046 |
| 58 | Recurrent abscess formation (HP:0002722) | 2.37557434 |
| 59 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.34213560 |
| 60 | Renal cortical cysts (HP:0000803) | 2.33083457 |
| 61 | Fatigue (HP:0012378) | 2.31461422 |
| 62 | Poor head control (HP:0002421) | 2.31088423 |
| 63 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.29772411 |
| 64 | Retrobulbar optic neuritis (HP:0100654) | 2.28741306 |
| 65 | Optic neuritis (HP:0100653) | 2.28741306 |
| 66 | Systemic lupus erythematosus (HP:0002725) | 2.26219431 |
| 67 | CNS demyelination (HP:0007305) | 2.25528161 |
| 68 | Hypoplasia of the uterus (HP:0000013) | 2.24894863 |
| 69 | Patchy hypopigmentation of hair (HP:0011365) | 2.23365880 |
| 70 | White forelock (HP:0002211) | 2.21385472 |
| 71 | Rhabdomyolysis (HP:0003201) | 2.20594262 |
| 72 | Hypoplasia of the thymus (HP:0000778) | 2.19906931 |
| 73 | Increased IgM level (HP:0003496) | 2.19644912 |
| 74 | Abnormal hair whorl (HP:0010721) | 2.19602671 |
| 75 | Methylmalonic aciduria (HP:0012120) | 2.18873458 |
| 76 | Asymmetric septal hypertrophy (HP:0001670) | 2.18235701 |
| 77 | Vacuolated lymphocytes (HP:0001922) | 2.17827338 |
| 78 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.16016906 |
| 79 | Cerebral hypomyelination (HP:0006808) | 2.15936713 |
| 80 | Birth length less than 3rd percentile (HP:0003561) | 2.14291748 |
| 81 | Pancytopenia (HP:0001876) | 2.14072156 |
| 82 | IgG deficiency (HP:0004315) | 2.13660981 |
| 83 | Myoglobinuria (HP:0002913) | 2.12646448 |
| 84 | Purpura (HP:0000979) | 2.11332441 |
| 85 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.09310330 |
| 86 | Neutropenia (HP:0001875) | 2.08602892 |
| 87 | Tongue fasciculations (HP:0001308) | 2.08588801 |
| 88 | Orchitis (HP:0100796) | 2.08550598 |
| 89 | Leukodystrophy (HP:0002415) | 2.07196310 |
| 90 | Recurrent bronchitis (HP:0002837) | 2.06746352 |
| 91 | Neoplasm of head and neck (HP:0012288) | 2.04966721 |
| 92 | Esophageal neoplasm (HP:0100751) | 2.04966721 |
| 93 | Ketosis (HP:0001946) | 2.03912059 |
| 94 | Neuroendocrine neoplasm (HP:0100634) | 2.03890822 |
| 95 | Lethargy (HP:0001254) | 2.02220390 |
| 96 | Albinism (HP:0001022) | 2.00054472 |
| 97 | Hypokinesia (HP:0002375) | 1.99368530 |
| 98 | Abnormality of the basal ganglia (HP:0002134) | 1.98169949 |
| 99 | Gingival bleeding (HP:0000225) | 1.97339339 |
| 100 | Ketoacidosis (HP:0001993) | 1.97254082 |
| 101 | Reticulocytopenia (HP:0001896) | 1.97230282 |
| 102 | Abolished electroretinogram (ERG) (HP:0000550) | 1.95867334 |
| 103 | Recurrent bacterial skin infections (HP:0005406) | 1.95148111 |
| 104 | Abnormality of methionine metabolism (HP:0010901) | 1.95044916 |
| 105 | Metaphyseal dysplasia (HP:0100255) | 1.94905767 |
| 106 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.94877531 |
| 107 | Dicarboxylic aciduria (HP:0003215) | 1.94877531 |
| 108 | 11 pairs of ribs (HP:0000878) | 1.94572666 |
| 109 | Loss of speech (HP:0002371) | 1.94114977 |
| 110 | Abnormality of the anterior horn cell (HP:0006802) | 1.93874427 |
| 111 | Degeneration of anterior horn cells (HP:0002398) | 1.93874427 |
| 112 | Respiratory difficulties (HP:0002880) | 1.93452353 |
| 113 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.93424567 |
| 114 | Hepatosplenomegaly (HP:0001433) | 1.92953762 |
| 115 | Neoplasm of the adrenal gland (HP:0100631) | 1.92932966 |
| 116 | Progressive neurologic deterioration (HP:0002344) | 1.92579089 |
| 117 | Premature graying of hair (HP:0002216) | 1.92295284 |
| 118 | Glycosuria (HP:0003076) | 1.90511727 |
| 119 | Abnormality of urine glucose concentration (HP:0011016) | 1.90511727 |
| 120 | Nausea (HP:0002018) | 1.90458425 |
| 121 | Emotional lability (HP:0000712) | 1.89697634 |
| 122 | Abnormality of T cell physiology (HP:0011840) | 1.88738752 |
| 123 | Gliosis (HP:0002171) | 1.87888271 |
| 124 | Testicular neoplasm (HP:0010788) | 1.87393504 |
| 125 | Abnormality of the renal cortex (HP:0011035) | 1.86103733 |
| 126 | Hypoglycemic seizures (HP:0002173) | 1.85443291 |
| 127 | Methylmalonic acidemia (HP:0002912) | 1.83916415 |
| 128 | Mucosal telangiectasiae (HP:0100579) | 1.83550362 |
| 129 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.82960782 |
| 130 | Hyperglycinemia (HP:0002154) | 1.81310422 |
| 131 | Agnosia (HP:0010524) | 1.78684411 |
| 132 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.77949224 |
| 133 | Pheochromocytoma (HP:0002666) | 1.77610088 |
| 134 | Autoimmune hemolytic anemia (HP:0001890) | 1.77359825 |
| 135 | Type 2 muscle fiber atrophy (HP:0003554) | 1.76054648 |
| 136 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.74798702 |
| 137 | Abnormality of T cells (HP:0002843) | 1.74282987 |
| 138 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.74200883 |
| 139 | Hyperammonemia (HP:0001987) | 1.73578466 |
| 140 | Abnormality of macrophages (HP:0004311) | 1.72929740 |
| 141 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.72887928 |
| 142 | Renal tubular dysfunction (HP:0000124) | 1.71739168 |
| 143 | Encephalitis (HP:0002383) | 1.71434028 |
| 144 | Recurrent pneumonia (HP:0006532) | 1.69766393 |
| 145 | Palpitations (HP:0001962) | 1.68552622 |
| 146 | Pulmonary fibrosis (HP:0002206) | 1.67729586 |
| 147 | Oral leukoplakia (HP:0002745) | 1.66257451 |
| 148 | Optic disc pallor (HP:0000543) | 1.65474354 |
| 149 | Muscle fibrillation (HP:0010546) | 1.65346388 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK16 | 4.46022074 |
| 2 | MAP4K2 | 4.17994697 |
| 3 | BUB1 | 3.45831518 |
| 4 | TSSK6 | 2.58409628 |
| 5 | MAP3K12 | 2.53262307 |
| 6 | PIM2 | 2.45382080 |
| 7 | EIF2AK3 | 2.39095039 |
| 8 | EIF2AK1 | 2.35437142 |
| 9 | NME2 | 2.29726938 |
| 10 | TIE1 | 2.26280094 |
| 11 | CCNB1 | 2.16792381 |
| 12 | LMTK2 | 2.16781281 |
| 13 | CDK19 | 2.13165078 |
| 14 | TEC | 2.11555311 |
| 15 | BCKDK | 2.04534590 |
| 16 | VRK1 | 2.03533763 |
| 17 | ARAF | 2.02325383 |
| 18 | IRAK4 | 1.94332337 |
| 19 | SIK3 | 1.91668199 |
| 20 | NUAK1 | 1.88166690 |
| 21 | TGFBR1 | 1.82262610 |
| 22 | EPHA3 | 1.80128698 |
| 23 | MAP4K1 | 1.76200199 |
| 24 | BMPR2 | 1.73901657 |
| 25 | PRPF4B | 1.64856355 |
| 26 | VRK2 | 1.59708174 |
| 27 | MST4 | 1.57580645 |
| 28 | NLK | 1.55027350 |
| 29 | EPHB1 | 1.53796407 |
| 30 | CDK8 | 1.50565677 |
| 31 | BRSK2 | 1.48997066 |
| 32 | IRAK2 | 1.48738765 |
| 33 | WEE1 | 1.46724330 |
| 34 | MYLK | 1.42785238 |
| 35 | AKT3 | 1.39410250 |
| 36 | PDK2 | 1.33478807 |
| 37 | CASK | 1.29722053 |
| 38 | TXK | 1.28995740 |
| 39 | PASK | 1.27039309 |
| 40 | STK10 | 1.23976788 |
| 41 | OBSCN | 1.23719082 |
| 42 | FRK | 1.23336724 |
| 43 | NME1 | 1.23150380 |
| 44 | BTK | 1.22210971 |
| 45 | ERBB3 | 1.21867334 |
| 46 | BLK | 1.19551170 |
| 47 | KIT | 1.18011833 |
| 48 | PBK | 1.17112818 |
| 49 | IRAK3 | 1.14763180 |
| 50 | MARK3 | 1.14192072 |
| 51 | BRAF | 1.13347853 |
| 52 | SRPK1 | 1.13038305 |
| 53 | JAK1 | 1.06199249 |
| 54 | TNIK | 1.04931356 |
| 55 | ACVR1B | 1.04729796 |
| 56 | PTK2B | 1.03268013 |
| 57 | TRIM28 | 1.01351848 |
| 58 | MAP3K3 | 1.00802046 |
| 59 | FER | 1.00346490 |
| 60 | TNK2 | 0.99498390 |
| 61 | TESK2 | 0.98667433 |
| 62 | NEK9 | 0.98249713 |
| 63 | DAPK1 | 0.97441393 |
| 64 | PINK1 | 0.96874134 |
| 65 | TGFBR2 | 0.94400113 |
| 66 | FLT3 | 0.93982406 |
| 67 | FES | 0.93330241 |
| 68 | NEK1 | 0.93309706 |
| 69 | ZAP70 | 0.91259396 |
| 70 | MKNK1 | 0.90533186 |
| 71 | SYK | 0.88902726 |
| 72 | CSNK1G1 | 0.87550823 |
| 73 | GRK1 | 0.85580609 |
| 74 | TESK1 | 0.85571523 |
| 75 | ZAK | 0.83896631 |
| 76 | MAP3K14 | 0.81627887 |
| 77 | TBK1 | 0.80816244 |
| 78 | GRK7 | 0.80689328 |
| 79 | CSF1R | 0.80168030 |
| 80 | KDR | 0.79597553 |
| 81 | PHKG1 | 0.78594679 |
| 82 | PHKG2 | 0.78594679 |
| 83 | MAP3K11 | 0.77763050 |
| 84 | RPS6KA4 | 0.75704025 |
| 85 | CSNK1G3 | 0.75633291 |
| 86 | JAK3 | 0.75108929 |
| 87 | PAK3 | 0.74841568 |
| 88 | GRK6 | 0.73935408 |
| 89 | MAP3K5 | 0.72678394 |
| 90 | PRKAA2 | 0.71102220 |
| 91 | WNK3 | 0.70679519 |
| 92 | CLK1 | 0.69690685 |
| 93 | LIMK1 | 0.69458517 |
| 94 | IKBKE | 0.69214946 |
| 95 | OXSR1 | 0.67877160 |
| 96 | MAP2K6 | 0.66754899 |
| 97 | PLK3 | 0.65401846 |
| 98 | PRKCE | 0.65300404 |
| 99 | BRSK1 | 0.64685945 |
| 100 | MAPKAPK5 | 0.63556242 |
| 101 | BCR | 0.62863170 |
| 102 | RIPK4 | 0.61191843 |
| 103 | JAK2 | 0.60846181 |
| 104 | RPS6KA6 | 0.59764439 |
| 105 | PRKG2 | 0.59388182 |
| 106 | IKBKB | 0.57364404 |
| 107 | CSK | 0.55855037 |
| 108 | RPS6KA5 | 0.55391861 |
| 109 | BMPR1B | 0.55352070 |
| 110 | TLK1 | 0.55209971 |
| 111 | MUSK | 0.54565927 |
| 112 | ATR | 0.54056204 |
| 113 | DAPK2 | 0.52703057 |
| 114 | PIK3CG | 0.52287087 |
| 115 | LYN | 0.52269828 |
| 116 | TYK2 | 0.52090668 |
| 117 | PRKCQ | 0.52086903 |
| 118 | HCK | 0.51931191 |
| 119 | CAMK2D | 0.51585933 |
| 120 | CAMKK2 | 0.51544231 |
| 121 | RPS6KB2 | 0.51077345 |
| 122 | RPS6KC1 | 0.50201531 |
| 123 | RPS6KL1 | 0.50201531 |
| 124 | IGF1R | 0.47789299 |
| 125 | MAPKAPK3 | 0.47193349 |
| 126 | PLK1 | 0.46873925 |
| 127 | AURKB | 0.45979555 |
| 128 | SCYL2 | 0.45622275 |
| 129 | CDC7 | 0.45598833 |
| 130 | ADRBK2 | 0.45567885 |
| 131 | CSNK2A1 | 0.45498251 |
| 132 | PLK2 | 0.43956756 |
| 133 | CSNK1G2 | 0.43386658 |
| 134 | YES1 | 0.42733541 |
| 135 | PRKCD | 0.41982412 |
| 136 | ITK | 0.41888416 |
| 137 | TRPM7 | 0.41149674 |
| 138 | MAP2K3 | 0.40425174 |
| 139 | TAOK2 | 0.39670642 |
| 140 | PIM1 | 0.39179904 |
| 141 | ABL2 | 0.39094883 |
| 142 | TAOK3 | 0.38764055 |
| 143 | IRAK1 | 0.38589761 |
| 144 | DYRK3 | 0.37689890 |
| 145 | CSNK2A2 | 0.37266173 |
| 146 | CDK7 | 0.36999652 |
| 147 | AURKA | 0.35561004 |
| 148 | ILK | 0.35389323 |
| 149 | LCK | 0.34001121 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 4.30263041 |
| 2 | Protein export_Homo sapiens_hsa03060 | 3.90742915 |
| 3 | DNA replication_Homo sapiens_hsa03030 | 3.57785262 |
| 4 | Mismatch repair_Homo sapiens_hsa03430 | 3.02692560 |
| 5 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.01154120 |
| 6 | Ribosome_Homo sapiens_hsa03010 | 2.94719461 |
| 7 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.62081918 |
| 8 | Base excision repair_Homo sapiens_hsa03410 | 2.59249133 |
| 9 | Parkinsons disease_Homo sapiens_hsa05012 | 2.52486030 |
| 10 | RNA polymerase_Homo sapiens_hsa03020 | 2.43684560 |
| 11 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.24505629 |
| 12 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.18337932 |
| 13 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.11153217 |
| 14 | Homologous recombination_Homo sapiens_hsa03440 | 1.84769002 |
| 15 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.78933099 |
| 16 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.75438683 |
| 17 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.70248918 |
| 18 | Huntingtons disease_Homo sapiens_hsa05016 | 1.70203364 |
| 19 | Alzheimers disease_Homo sapiens_hsa05010 | 1.64861510 |
| 20 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.62124110 |
| 21 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.60976199 |
| 22 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.59916393 |
| 23 | Spliceosome_Homo sapiens_hsa03040 | 1.57227580 |
| 24 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.44901474 |
| 25 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.44119763 |
| 26 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.43754987 |
| 27 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.42241738 |
| 28 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.40990292 |
| 29 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.38254502 |
| 30 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.34560793 |
| 31 | Purine metabolism_Homo sapiens_hsa00230 | 1.30116812 |
| 32 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.27193789 |
| 33 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.26634324 |
| 34 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.22622951 |
| 35 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.21564776 |
| 36 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.19859660 |
| 37 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.19595743 |
| 38 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.16754867 |
| 39 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.13522491 |
| 40 | RNA degradation_Homo sapiens_hsa03018 | 1.12635101 |
| 41 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.10491914 |
| 42 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.05414112 |
| 43 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.05198279 |
| 44 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.05040512 |
| 45 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.04412088 |
| 46 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.04298909 |
| 47 | Carbon metabolism_Homo sapiens_hsa01200 | 1.02391823 |
| 48 | Asthma_Homo sapiens_hsa05310 | 1.01571230 |
| 49 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.00881476 |
| 50 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.00550631 |
| 51 | Legionellosis_Homo sapiens_hsa05134 | 0.99896704 |
| 52 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.99782663 |
| 53 | Other glycan degradation_Homo sapiens_hsa00511 | 0.98791125 |
| 54 | RNA transport_Homo sapiens_hsa03013 | 0.98588443 |
| 55 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.98061742 |
| 56 | Basal transcription factors_Homo sapiens_hsa03022 | 0.97461940 |
| 57 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.97291272 |
| 58 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.94689583 |
| 59 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.94636802 |
| 60 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.92650242 |
| 61 | Circadian rhythm_Homo sapiens_hsa04710 | 0.91995648 |
| 62 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.91295881 |
| 63 | Sulfur relay system_Homo sapiens_hsa04122 | 0.84930842 |
| 64 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.83347815 |
| 65 | Galactose metabolism_Homo sapiens_hsa00052 | 0.82055716 |
| 66 | Phagosome_Homo sapiens_hsa04145 | 0.81818630 |
| 67 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.81423419 |
| 68 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.78745782 |
| 69 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.77888251 |
| 70 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.75790137 |
| 71 | Metabolic pathways_Homo sapiens_hsa01100 | 0.74695407 |
| 72 | Cell cycle_Homo sapiens_hsa04110 | 0.73851048 |
| 73 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.72112172 |
| 74 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.71406668 |
| 75 | Lysosome_Homo sapiens_hsa04142 | 0.69091684 |
| 76 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.68086724 |
| 77 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.67024108 |
| 78 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.66535207 |
| 79 | Malaria_Homo sapiens_hsa05144 | 0.66441568 |
| 80 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.64518276 |
| 81 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.64354295 |
| 82 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.63691010 |
| 83 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.63565367 |
| 84 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.63374740 |
| 85 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.63242873 |
| 86 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.62426671 |
| 87 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.60528267 |
| 88 | Peroxisome_Homo sapiens_hsa04146 | 0.60009543 |
| 89 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.59465097 |
| 90 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.59360862 |
| 91 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.58617778 |
| 92 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.58222638 |
| 93 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.56194037 |
| 94 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.55073688 |
| 95 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.53330462 |
| 96 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.52480263 |
| 97 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.52447493 |
| 98 | Pertussis_Homo sapiens_hsa05133 | 0.51767040 |
| 99 | Mineral absorption_Homo sapiens_hsa04978 | 0.51154798 |
| 100 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.50695449 |
| 101 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.50647854 |
| 102 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.50447550 |
| 103 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.50329625 |
| 104 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.50242482 |
| 105 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.48402024 |
| 106 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.46985415 |
| 107 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.46670414 |
| 108 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.45252355 |
| 109 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.44549002 |
| 110 | Shigellosis_Homo sapiens_hsa05131 | 0.44029004 |
| 111 | Salmonella infection_Homo sapiens_hsa05132 | 0.43492196 |
| 112 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.42944438 |
| 113 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.42356451 |
| 114 | Histidine metabolism_Homo sapiens_hsa00340 | 0.39957913 |
| 115 | Leishmaniasis_Homo sapiens_hsa05140 | 0.39084913 |
| 116 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.38283998 |
| 117 | Measles_Homo sapiens_hsa05162 | 0.38073488 |
| 118 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.37687718 |
| 119 | Allograft rejection_Homo sapiens_hsa05330 | 0.37424683 |
| 120 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.36900784 |
| 121 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.35166021 |
| 122 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.33825376 |
| 123 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.30634212 |
| 124 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.28508257 |
| 125 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.25560288 |
| 126 | Influenza A_Homo sapiens_hsa05164 | 0.23734119 |
| 127 | Apoptosis_Homo sapiens_hsa04210 | 0.23408728 |
| 128 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.23060871 |
| 129 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.22633049 |
| 130 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.21189712 |
| 131 | Tuberculosis_Homo sapiens_hsa05152 | 0.20375967 |

